Internal Medicine, Pulmonary Disease · Vincennes, IN
NPI
1740272251
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
520 S 7th St
Vincennes, IN, 47591
Phone (812) 885-3243
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
2,051 services
Medicare patients, 2024
738
Average age 74
Drug cost, 2024
$4.9M
8,765 prescriptions
Company payments, 2025
$6,889
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Johnathan R Grant was code 99214 (office e&m - established), 679 times for 419 patients. In total Johnathan R Grant billed 2,051 services in 22 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 679 | 419 | $67.08 | $46K |
| 99213 Office E&M - Established | Facility | 383 | 300 | $44.11 | $17K |
| 94060 Pulmonary Function Testing | Facility | 240 | 228 | $7.30 | $1,753 |
| 94726 Pulmonary Function Testing | Facility | 235 | 225 | $8.53 | $2,004 |
| 94729 Pulmonary Function Testing | Facility | 235 | 225 | $6.30 | $1,479 |
| 94618 Pulmonary Function Testing | Facility | 152 | 134 | $15.36 | $2,335 |
| 99215 Office E&M - Established | Facility | 33 | 27 | $99.59 | $3,286 |
| 99204 Office E&M - New | Facility | 25 | 25 | $93.83 | $2,346 |
| 99205 Office E&M - New | Facility | 21 | 21 | $110.67 | $2,324 |
| 31624 Bronchoscopy | Facility | 17 | 17 | $62.98 | $1,071 |
By year: 2022 $97K for 2,494 services; 2023 $99K for 2,487 services; 2024 $82K for 2,051 services.
Medicare prescription drug claims, 2024
In 2024, the drug Johnathan R Grant prescribed most often to Medicare patients was Theophylline Er (Theophylline Anhydrous), with 1,099 prescriptions and refills. In total Johnathan R Grant wrote 8,765 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Theophylline Er Theophylline Anhydrous | 1,099 | 1,749 | 201 | $62K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 761 | 951 | 130 | $600K |
| Montelukast Sodium Generic | 695 | 1,369 | 146 | $5,783 |
| Roflumilast Generic | 550 | 699 | 91 | $38K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 549 | 660 | 145 | $16K |
| Azithromycin Generic | 427 | 539 | 88 | $5,639 |
| Prednisone Generic | 376 | 514 | 75 | $1,541 |
| Spiriva Respimat Tiotropium Bromide | 333 | 381 | 60 | $197K |
| Omeprazole Generic | 332 | 626 | 73 | $4,053 |
| Pantoprazole Sodium Generic | 291 | 498 | 54 | $4,563 |
| Famotidine Generic | 259 | 473 | 54 | $2,835 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 180 | 269 | 30 | $126K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 157 | 171 | 28 | $108K |
| Ofev Nintedanib Esylate | 143 | 147 | 19 | $1.9M |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 128 | 150 | 25 | $66K |
Brand drugs: 3,095 claims; generic drugs: 5,670 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Johnathan R Grant $6,889 ($6,889 in general payments such as food, travel and fees) from 21 companies. The largest payer was Intuitive Surgical, Inc. with $5,613.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 11 | $5,613 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $200 |
| Actelion Pharmaceuticals US, Inc. JNJ | 7 | $182 |
| GlaxoSmithKline, LLC. GSK | 20 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $97.71 |
| Verona Pharma, Inc. VRNA | 4 | $67.79 |
| Genzyme Corporation SNY | 4 | $63.17 |
| Insmed, Inc. INSM | 4 | $62.71 |
| Merck Sharp & Dohme LLC MRK | 4 | $62.14 |
| United Therapeutics Corporation UTHR | 3 | $57.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.